Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-26-002503
Filing Date
2026-01-09
Accepted
2026-01-09 16:34:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 tm2528395-3_f3.htm 424B3 656849
2 GRAPHIC lg_adagene-4clr.jpg GRAPHIC 8040
3 GRAPHIC fc_corporate-bw.jpg GRAPHIC 42260
  Complete submission text file 0001104659-26-002503.txt   724040
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-291196 | Film No.: 26523473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)